5-7-dihydroxy-6-methoxy-2-phenylchromen-4-one and Acute-Lung-Injury

5-7-dihydroxy-6-methoxy-2-phenylchromen-4-one has been researched along with Acute-Lung-Injury* in 2 studies

Other Studies

2 other study(ies) available for 5-7-dihydroxy-6-methoxy-2-phenylchromen-4-one and Acute-Lung-Injury

ArticleYear
Inhibition of miR-155 potentially protects against lipopolysaccharide-induced acute lung injury through the IRF2BP2-NFAT1 pathway.
    American journal of physiology. Cell physiology, 2020, 12-01, Volume: 319, Issue:6

    Sepsis-induced lung injury is a lethal complication with no effective treatment options, affecting millions of people worldwide. Oroxylin A (OroA) is a natural flavonoid with potent anticancer effects, but its modulating effect on inflammation through microRNAs (miRs) is not apparent. In this report, we investigated the target genes of the miR pathway mediated by OroA and assessed the potential for novel treatments of septic lung injury. An miR array screening and quantitative polymerase chain reaction identified that miR-155-5p could be a candidate regulated by OroA. Bioinformatics analysis indicated that interferon regulatory factor-2-binding protein-2 (IRF2BP2) might be a target of miR-155-5p, and this hypothesis was verified through reporter assays. In addition, an immunoprecipitation assay demonstrated that OroA increased the binding activity of IRF2BP2 to the nuclear factor of activated T-cells 1 (NFAT1), causing inducible nitric oxide synthase to cause an inflammatory reaction. Finally, the direct injection of short hairpin RNA (shRNA)-miR-155-5p into the bone marrow of mice ameliorated LPS-induced acute lung injury and inflammation in mice. Our results provide new mechanistic insights into the role of the OroA-induced miR-155-5p-IRF2BP2-NFAT1 axis in sepsis, demonstrating that direct bone marrow injection of lentivirus containing shRNA-155-5p could prove to be a potential future clinical application in alleviating sepsis-induced acute lung injury.

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Flavonoids; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; MicroRNAs; NFATC Transcription Factors; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; Sepsis; Transcription Factors

2020
Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents.
    PloS one, 2012, Volume: 7, Issue:10

    Successful drug treatment for sepsis-related acute lung injury (ALI) remains a major clinical problem. This study was designed to assess the beneficial effects of post-treatment of oroxylin A (OroA), a flavonoid, in ameliorating lipopolysaccharides (LPS)-induced lung inflammation and fatality.. Rats were injected with LPS (10 mg/kg, iv) to induce ALI, and OroA was given (15 mg/kg, iv) 1 hr or 6 hrs after LPS challenge. Twenty four hrs after LPS challenge, biochemical changes in the blood and lung tissues, and morphological/histological alterations in the lung associated with inflammation and injury were examined. Therapeutic effect of OroA was assessed by measuring the survival rate in endotoxemic mice.. LPS (10 mg/kg, iv) significantly altered WBC counts, elevated plasma tumor necrosis factor (TNF)-α and nitric oxide (NO), increased pulmonary edema, thickened alveolar septa, and decreased survival rate. These changes were ameliorated by OroA (15 mg/kg, iv) administered 1 hr or 6 hrs after LPS challenge. This post-treatment also significantly attenuated LPS-induced activation of nuclear factor-κB (NF-κB) and the release of high mobility group box 1 (HMGB1) in lung tissues. Furthermore, post-treatment with OroA (60 mg/kg, ip) administered 1 hr or 6 hrs after LPS challenge in mice significantly increased survival rate.. OroA administered after induction of ALI by LPS significantly prevent and revere lung tissues injuries with increased survival rate. Positive post-treatment effects of OroA suggest that OroA is a potentially useful candidate for managing lung inflammation in LPS-induced endotoxemia and septic shock.

    Topics: Acute Lung Injury; Analysis of Variance; Animals; Flavonoids; Fluorescent Antibody Technique; Immunoassay; Immunohistochemistry; Leukocyte Count; Lipopolysaccharides; Male; Mice; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha

2012